EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Engineered αvβ6-targeting peptide‒BSH conjugates for boron neutron capture therapy of pancreatic ductal adenocarcinoma

Linger Li, Xin Gao, Siqi Zhang, Xingkai Wang, Xueyao Chen, Yuan Miao, Tongtong Zhang, Mengjie Yang, Can Liu, Tianjiao Liang, Tiancheng Yi, Shuo Jiang und 5 weitere

Acta Pharmaceutica Sinica B · 2026-11 · 16 (11) · 7535-7553

DOI: 10.1016/j.apsb.2026.05.012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Pharmaceutica Sinica B, 2026-11. Verfasst von Linger Li und 16 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and P…. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Chinese Academy of Medical Sciences, National Natural Science Foundation of China, Beijing Nova Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Boron neutron capture therapyPET/CTPancreatic ductal adenocarcinomaPeptideTheranosticsαvβ6

Autor:innen und Institutionen

  • State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
  • Beijing Key Laboratory of Targeted Radiopharmaceutical Development and Translational Nuclear Medicine, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, Chi…
  • Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China.
  • China Spallation Neutron Source Center, Dongguan 523803, China.
  • Key Laboratory of Preclinical Study for New Drugs of Gansu Province, School of Basic Medical Sciences & Research Unit of Peptide Science, Chinese Academy of Medical Sciences, Lanzhou University, Lanzhou 730000, China.

Förderung

  • Chinese Academy of Medical Sciences
  • National Natural Science Foundation of China
  • Beijing Nova Program
  • Natural Science Foundation of Beijing Municipality
  • Chinese Academy of Medical Sciences Initiative for Innovative Medicine

Zitieren

APA

Li, L., Gao, X., Zhang, S., Wang, X., Chen, X., Miao, Y., Zhang, T., Yang, M., Liu, C., Liang, T., Yi, T., Jiang, S., Huang, H., Zhang, H., Tong, J., Wang, R., & Hu, K. (2026). Engineered αvβ6-targeting peptide‒BSH conjugates for boron neutron capture therapy of pancreatic ductal adenocarcinoma. Acta Pharmaceutica Sinica B, 16(11), 7535-7553. https://doi.org/10.1016/j.apsb.2026.05.012

Vancouver

Li L, Gao X, Zhang S, Wang X, Chen X, Miao Y, et al. Engineered αvβ6-targeting peptide‒BSH conjugates for boron neutron capture therapy of pancreatic ductal adenocarcinoma. Acta Pharmaceutica Sinica B. 2026;16(11):7535-7553. doi:10.1016/j.apsb.2026.05.012

BibTeX
@article{Li2026,
  author = {Li, Linger and Gao, Xin and Zhang, Siqi and Wang, Xingkai and Chen, Xueyao and Miao, Yuan and Zhang, Tongtong and Yang, Mengjie and Liu, Can and Liang, Tianjiao and Yi, Tiancheng and Jiang, Shuo and Huang, Hongyi and Zhang, Hailong and Tong, Jianfei and Wang, Rui and Hu, Kuan},
  title = {Engineered αvβ6-targeting peptide‒BSH conjugates for boron neutron capture therapy of pancreatic ductal adenocarcinoma},
  journal = {Acta Pharmaceutica Sinica B},
  year = {2026},
  volume = {16},
  number = {11},
  pages = {7535--7553},
  doi = {10.1016/j.apsb.2026.05.012}
}
Kostenlos starten →